10 tablets in a blister, 2 blisters in a cardboard box.
The drug is used to prevent and treat dogs and cats liver diseases (hepatitis of various etiologies), cholecystitis; in the complex treatment of heart pathologies (myocarditis, cardiomyopathy, coronary artery disease); metabolic disturbances; postoperative complications
PACKAGING
10 tablets in a blister, 2 blisters in a cardboard box.
СOMPOSITION
1 tablet (0.3 g) contains active substances: thiotriazolin – 0,1 g
DESCRIPTION. Tablets of white color with little darkish inclusions.
PHARMACOLOGICAL CHARACTERISTICS. The active substance of the drug thiotriazolin has expressed membranostabilizing, antioxidant, reparative and immunomodulatory activity, also reveals some antiischemic action. The mechanism of action of thiotriazoline provides ability to enhance compensatory activation of anaerobic glycolysis and activate the oxidation processes in the Krebs cycle without changing of intracellular ATP fund. The substance activates the antioxidant system and inhibits lipid oxidation processes in ischemic areas of the myocardium, reduces the sensitivity of the myocardium to catecholamines, prevents progressive inhibition of the contractile function of the heart, stabilizes and reduces zones of necrosis and myocardial ischemia. In addition, thiotriazolin normalizes metabolic processes in the myocardium, helps to normalize heart rate and improves rheological properties of blood due to activation of the fibrinolytic system.
The drug has pronounced hepatoprotective properties, prevents the destruction of hepatocytes and stimulates their regeneration, reduces the spread of necrosis and fatty infiltration of the liver; normalizes protein, carbohydrate, lipid and pigment exchanges; accelerates the synthesis and secretion of bile, normalize its chemical composition.
APPLICATION.The drug is used to prevent and treat dogs and cats liver diseases (hepatitis of various etiologies), cholecystitis; in the complex treatment of heart pathologies (myocarditis, cardiomyopathy, coronary artery disease); metabolic disturbances; postoperative complications.
DOSAGE.The drug is used orally at doses givenin the table. Duration of drug application – 14 days; in a postoperative period – 20 days.
Type of animal | Body weight | Dose per animal and multiplicity of application |
dogs | to 10 kg | 1/2 tablet 2 times a day |
dogs | 10-20 kg | 1 tablet 2 times a day |
dogs | 20 kg and more | 1 tablet 3 times a day |
cats | to 3 kg | 1/4 tablet 2 times a day |
cats | 3 kg and more | 1/2 tablet 2 times a day |
CONTRAINDICATIONS.Do not apply to animals with renal insufficiency.
PRECAUTIONS.The product can be used in conjunction with agents in traditional methods of treatment of hepatitis; application can be combined with basic agents of therapy for coronary heart disease.
STORAGE.Store in a dry, dark place at temperature not more than 25°C.
Expiration date of the drug – 3 yearsfrom manufacturing date.